Opinion & analysis | Page 5 of 9 | Report Store

J&J Scores Early In ‘Hypoallergenic’ Case; Plaintiff’s Definition ‘Implausible,’ Court Says

$200.00

What’s the meaning of “hypoallergenic”? Judges in the federal court Northern District have disagreed, with a judge recently siding with Johnson & Johnson’s definition of the term as part of an ongoing lawsuit. Find out more about the suit and its implications for your business in this article from Rose Sheet.

June 27, 2018

Moving Medical Affairs To The Pharma Forefront

J&J Scores Early In ‘Hypoallergenic’ Case; Plaintiff’s Definition ‘Implausible,’ Court Says

Thinking about using CMMI? Here are tips from the experts

It’s Complicated: FDA Prohibits CBD In Supplements, Enforcement Priority On Disease Claims

The Blockbusters No One Talks About

Pharma’s New R&D Models: Federating Innovation

Bayer’s US Playbook: The Smart Way To Top-Line Growth

Roche’s External Control Arms Show What Real-World Evidence Can Look Like In Practice

New Reasons Not To Use EU MDR’s Four-Year Extension, But Comply Earlier Or Retire Products Instead

Paying For Gene Therapy: Will Pharma Be First In Line?

Cosmetic Preservatives Crisis Creeping Into CIR Program

Next-Generation Roche: How Data Analytics Will Keep It In The Lead In Oncology

EMA To Re-Prioritize Tasks To Cope With ‘Higher Than Expected’ Staff Losses

Colgate/Tom’s Of Maine Pays Back Unilever For ‘Naturally Dry’ Loss

Novartis’ New Oncology CEO Liz Barrett Charts A Course, But It Will Require Jump-Starting New Brands